Sodium butyrate inhibits histone deacetylation in cultured cells.
about
Dietary, metabolic, and potentially environmental modulation of the lysine acetylation machineryThe ETO protein disrupted in t(8;21)-associated acute myeloid leukemia is a corepressor for the promyelocytic leukemia zinc finger proteinMitogen-stimulated phosphorylation of histone H3 is targeted to a small hyperacetylation-sensitive fractionA direct link between core histone acetylation and transcriptionally active chromatinThe microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colonSubstrate-induced regulation of the human colonic monocarboxylate transporter, MCT1Histone Deacetylases and Their Inhibition in Candida SpeciesHistone Acetylation and Its Modifiers in the Pathogenesis of Diabetic NephropathyGPR41 and GPR43 in Obesity and Inflammation - Protective or Causative?Butyrate, neuroepigenetics and the gut microbiome: Can a high fiber diet improve brain health?Influences of diet and the gut microbiome on epigenetic modulation in cancer and other diseasesImproving cereal grain carbohydrates for diet and healthConcise Review: Energy Metabolites: Key Mediators of the Epigenetic State of PluripotencyING1 and 5-azacytidine act synergistically to block breast cancer cell growthThe Effect of Microbiota and the Immune System on the Development and Organization of the Enteric Nervous SystemStable histone deacetylase complexes distinguished by the presence of SANT domain proteins CoREST/kiaa0071 and Mta-L1Differential association of products of alternative transcripts of the candidate tumor suppressor ING1 with the mSin3/HDAC1 transcriptional corepressor complexHistone H4 acetylation in human cells. Frequency of acetylation at different sites defined by immunolabeling with site-specific antibodiesFunctional and molecular effects of arginine butyrate and prednisone on muscle and heart in the mdx mouse model of Duchenne Muscular DystrophyEffects of Sodium Butyrate Treatment on Histone Modifications and the Expression of Genes Related to Epigenetic Regulatory Mechanisms and Immune Response in European Sea Bass (Dicentrarchus Labrax) Fed a Plant-Based DietButyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanismsHistone deacetylase inhibitors for cancer therapy: An evolutionarily ancient resistance response may explain their limited successCommensal microbe-derived butyrate induces the differentiation of colonic regulatory T cellsThe Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and menAnalyses of Histone Proteoforms Using Front-end Electron Transfer Dissociation-enabled Orbitrap Instruments.Pitfalls in global normalization of ChIP-seq data in CD4(+) T cells treated with butyrate: A possible solution strategy.Using atomic force microscopy to study chromatin structure and nucleosome remodeling.An unfolded protein response is the initial cellular response to the expression of mutant matrilin-3 in a mouse model of multiple epiphyseal dysplasia.Transient vs. prolonged histone hyperacetylation: effects on colon cancer cell growth, differentiation, and apoptosis.Overexpression of Srcin1 contributes to the growth and metastasis of colorectal cancer.Optimal response to thalidomide in a patient with thalassaemia major resistant to conventional therapyPreclinical studies of chemotherapy using histone deacetylase inhibitors in endometrial cancerProof-of-Concept Gene Editing for the Murine Model of Inducible Arginase-1 DeficiencyFrom 'omics' to complex disease: a systems biology approach to gene-environment interactions in cancer.Growth inhibition of pancreatic cancer cells by histone deacetylase inhibitor belinostat through suppression of multiple pathways including HIF, NFkB, and mTOR signaling in vitro and in vivoTreatment of spinal muscular atrophy by sodium butyrate.Human globin gene transcription in injected Xenopus oocytes: enhancement by sodium butyrate.Novel strategies and therapeutics for the treatment of prostate carcinoma.Modifying histones to tame cancer: clinical development of sodium phenylbutyrate and other histone deacetylase inhibitors.Chromatin modification and disease
P2860
Q21296850-3BA370B9-4070-4EB8-A1F5-9646BF477D5AQ24523980-EAB65AAF-369D-4863-A3D3-F386BE41DA05Q24563194-05D1F0F8-0785-439D-8AA0-57C604147421Q24563586-81F555BB-DB95-49C7-B144-26025CCAE9EEQ24632639-A6F64AB8-1614-42AC-9F91-F12EBD7ED08DQ24642366-E8E5DF55-D57B-413D-9FAD-BEC581C9E0A2Q26740146-C2140096-5389-4CAC-9B9D-42F08480180CQ26744442-03C9733D-DA5F-4174-9282-3260C5B2DC97Q26766417-4643E876-3C28-4892-B419-62F10C735736Q26766586-D70CC034-8CD0-446E-A74B-A6431864EC85Q26781968-3F5FB723-0458-466B-9961-49D833E4555FQ26997076-1D0897CC-2E9F-4A13-85B3-9591B25B40E7Q27002370-4D26DD35-8064-48D6-AA0A-5884006DE6B4Q27322757-EFA2BC66-4307-4178-B934-A442B752038CQ28072096-AFC8697A-D031-4238-A121-4A82D3CE41E2Q28139194-2C8F2C4F-1C05-4051-A33A-456512989D2EQ28140473-523B2385-4E38-405E-A587-3DC1F81AD8B0Q28238472-B67E251F-A71B-412A-A9CC-3211425D4FD2Q28474542-B49E81E2-92F1-4C6D-85B9-94E0E24F20ECQ28553330-AC268526-329D-46C1-A60F-114C61B38893Q28730663-121431B3-4150-4C09-A0FF-1934607D6CCDQ28822336-04A6E140-A786-450C-A3E2-66A10358E9BEQ29618126-B53298CF-98D8-482F-B875-77DF5A1ED0E0Q29619117-3E1F8FD1-0360-4423-ADEE-8184CF0B5F05Q30277719-135FAF57-6096-403A-A6FE-A1AC949D62A3Q30401001-8242689E-B5D4-4671-BB2D-25381300E468Q30496780-A410D709-E331-4560-AAAC-8495A70F15F6Q30497960-5C779BF6-3E99-4DEE-8235-F9A58A2176F2Q31919974-93D94FCD-5279-4286-8E22-7C48904FEBF2Q33598061-EEF74835-28A8-45CE-A947-BFE53C38E07EQ33603146-81336915-3BEB-4032-B6B3-A2727656ACD4Q33651762-4769D9E6-766B-4F23-8569-43E1A2E5EF53Q33747161-215B8B8A-B4F0-4972-A450-4F38253D4AFBQ33875700-2A34CC9A-5CF4-4A01-AB08-CB6575DFC740Q33927370-95DD1E83-DDE3-4373-9F50-91720AEA30F6Q33933841-5F1AE05D-F1F4-4A06-9F5C-C17288B01432Q33940155-74391541-221F-4EE5-9404-EACEA42A473DQ34043331-3CF849EA-FA36-4677-BC06-24C8B616637CQ34091001-DC3A972C-0C03-404B-9B9C-4C5CA555661DQ34098840-F5AC2F8D-BEE8-4594-9ACB-E73CEF6F9349
P2860
Sodium butyrate inhibits histone deacetylation in cultured cells.
description
1978 nî lūn-bûn
@nan
1978 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1978 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
name
Sodium butyrate inhibits histone deacetylation in cultured cells.
@ast
Sodium butyrate inhibits histone deacetylation in cultured cells.
@en
Sodium butyrate inhibits histone deacetylation in cultured cells.
@nl
type
label
Sodium butyrate inhibits histone deacetylation in cultured cells.
@ast
Sodium butyrate inhibits histone deacetylation in cultured cells.
@en
Sodium butyrate inhibits histone deacetylation in cultured cells.
@nl
prefLabel
Sodium butyrate inhibits histone deacetylation in cultured cells.
@ast
Sodium butyrate inhibits histone deacetylation in cultured cells.
@en
Sodium butyrate inhibits histone deacetylation in cultured cells.
@nl
P2093
P1433
P1476
Sodium butyrate inhibits histone deacetylation in cultured cells.
@en
P2093
P304
P356
10.1016/0092-8674(78)90305-7
P407
P577
1978-05-01T00:00:00Z